Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Differential Risks for Melanoma: p16 and DNA Repair

NCT00615095 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT00615095 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Differential Risks for Melanoma: p16 and DNA Repair
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Observational
Overall status
Completed
Start date
February 28, 1997
Completion date
April 30, 2011
Enrollment
323 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma, skin melanoma

Lead sponsor's other trials

Memorial Sloan Kettering Cancer Center, most recent start first.

Similar trials

Same condition (Melanoma) and phase, most recent start first.